In vitro inhibition of HUVECs by low dose methotrexate - Insights into oral adverse events
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Head & Face Medicine 10 (2014) 19, 1-7
- Event
-
Veröffentlichung
- (where)
-
Münster
- (who)
-
Universitäts- und Landesbibliothek Münster
- (when)
-
2014
- Creator
- URN
-
urn:nbn:de:hbz:6-01349481116
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Annussek, Tobias
- Szuwart, Thomas
- Kleinheinz, Johannes
- Koiky, Cathrin
- Wermker, Kai
- Universitäts- und Landesbibliothek Münster
Time of origin
- 2014
Other Objects (12)
In vitro inhibition of HUVECs by low dose methotrexate – insights into oral adverse events
Low-dose oral methotrexate-induced crystalluria
Palliative low dose fortnightly methotrexate in oral cancer
GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
High-dose Methotrexate
Adverse events of methotrexate treatment in JIA
Low dose methotrexate therapy in rheumatic diseases
Unsuccessful Treatment of Cheilitis Granulomatosa with Oral Methotrexate
Palliative low dose fortnightly methotrexate in oral cancers: Experience at a rural cancer centre from India
High dose methotrexate : pharmacology toxicology and chemotherapy ; proceedings of the High Dose Methotrexate International Workshop, June 13 - 14, 1978, Firenze, Italy
High-dose methotrexate : pharmacokinetics in children and young adults
High-dose methotrexate in ICU patients: a retrospective study
In vitro inhibition of HUVECs by low dose methotrexate – insights into oral adverse events
Low-dose oral methotrexate-induced crystalluria
Palliative low dose fortnightly methotrexate in oral cancer
GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
High-dose Methotrexate
Adverse events of methotrexate treatment in JIA
Low dose methotrexate therapy in rheumatic diseases
Unsuccessful Treatment of Cheilitis Granulomatosa with Oral Methotrexate
Palliative low dose fortnightly methotrexate in oral cancers: Experience at a rural cancer centre from India
High dose methotrexate : pharmacology toxicology and chemotherapy ; proceedings of the High Dose Methotrexate International Workshop, June 13 - 14, 1978, Firenze, Italy
High-dose methotrexate : pharmacokinetics in children and young adults
High-dose methotrexate in ICU patients: a retrospective study
In vitro inhibition of HUVECs by low dose methotrexate – insights into oral adverse events
Low-dose oral methotrexate-induced crystalluria
Palliative low dose fortnightly methotrexate in oral cancer
GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
High-dose Methotrexate
Adverse events of methotrexate treatment in JIA
Low dose methotrexate therapy in rheumatic diseases
Unsuccessful Treatment of Cheilitis Granulomatosa with Oral Methotrexate
Palliative low dose fortnightly methotrexate in oral cancers: Experience at a rural cancer centre from India
High dose methotrexate : pharmacology toxicology and chemotherapy ; proceedings of the High Dose Methotrexate International Workshop, June 13 - 14, 1978, Firenze, Italy
High-dose methotrexate : pharmacokinetics in children and young adults